News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,774 Results
Type
Article (88205)
Company Profile (823)
Press Release (784725)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233356)
Career Advice (4152)
Deals (39899)
Drug Delivery (158)
Drug Development (91483)
Employer Resources (205)
FDA (18444)
Job Trends (17442)
News (398150)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (166)
Alliances (56982)
ALS (193)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (381)
Approvals (18642)
Artificial intelligence (688)
Autoimmune disease (202)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (70)
Breast cancer (697)
Cancer (5370)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77464)
Collaboration (1973)
Company closure (6)
Compensation (1248)
Complete response letters (83)
COVID-19 (3005)
CRISPR (110)
C-suite (977)
Cystic fibrosis (157)
Data (6739)
Decentralized trials (2)
Denatured (77)
Depression (166)
Diabetes (556)
Diagnostics (7334)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (335)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (259)
Earnings (100829)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135955)
Executive appointments (1076)
FDA (21829)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1660)
Gene editing (234)
Generative AI (71)
Gene therapy (723)
GLP-1 (1172)
Government (5486)
Grass and pollen (8)
Guidances (389)
Healthcare (20985)
HIV (76)
Huntington's disease (56)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (77)
Indications (135)
Infectious disease (3324)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (717)
Lymphoma (397)
Machine learning (49)
Management (66)
Manufacturing (934)
MASH (186)
Medical device (15100)
Medtech (15168)
Mergers & acquisitions (23051)
Metabolic disorders (1493)
mRNA (202)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (391)
Neuropsychiatric disorders (110)
Neuroscience (3268)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (731)
Opinion (350)
Ovarian cancer (177)
Pain (235)
Pancreatic cancer (254)
Parkinson's disease (322)
Partnered (39)
Patents (550)
Patient recruitment (559)
Peanut (65)
People (67196)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23934)
Phase 2 (33617)
Phase 3 (25319)
Pipeline (6230)
Policy (360)
Postmarket research (3554)
Preclinical (10731)
Press Release (72)
Prostate cancer (273)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1027)
Real estate (7445)
Recruiting (81)
Regulatory (29383)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1194)
Venture capital (103)
Weight loss (498)
Women's health (106)
Worklife (23)
Date
Today (106)
Last 7 days (783)
Last 30 days (3317)
Last 365 days (32791)
2026 (6090)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51712)
Australia (9086)
California (12287)
Canada (3495)
China (1240)
Colorado (519)
Connecticut (537)
Delaware (364)
Europe (119015)
Florida (1823)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1027)
India (82)
Indiana (576)
Iowa (24)
Japan (471)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1524)
Massachusetts (9019)
Michigan (381)
Minnesota (695)
Mississippi (7)
Missouri (146)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3304)
New Mexico (33)
New York (3235)
North Carolina (1691)
North Dakota (10)
Northern California (5946)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2448)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4765)
Tennessee (194)
Texas (1938)
United States (44210)
Utah (370)
Vermont (1)
Virginia (310)
Washington D.C. (88)
Washington State (1017)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,774 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
Servier will pick up Ojemda, which received FDA approval in 2024 to treat pediatric glioma. The drug clocked sales of $155 million for Day One Biopharmaceuticals in 2025.
March 6, 2026
·
1 min read
·
Annalee Armstrong
Opinion
Direct-to-Consumer Drugs Are Not a Panacea for High Costs
TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.
March 6, 2026
·
4 min read
·
Michael Grosberg
Weight loss
Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar
Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.
March 6, 2026
·
3 min read
·
Tristan Manalac
Immuno-oncology
J&J Wins Third National Priority Approval for Multiple Myeloma Combo
The FDA granted Johnson & Johnson a Commissioner’s National Priority Voucher in December 2025 after the combination of Darzalex and Tecvayli improved progression-free survival by 83%. The new approval is for second-line treatment of the blood cancer.
March 6, 2026
·
2 min read
·
Tristan Manalac
Press Releases
McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences
March 6, 2026
·
1 min read
Press Releases
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology
March 6, 2026
·
1 min read
Press Releases
Valcare Medical Appoints Two New Members to Board of Directors
March 6, 2026
·
4 min read
Press Releases
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
March 6, 2026
·
11 min read
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 6, 2026
March 6, 2026
·
2 min read
Press Releases
Artelo Biosciences Announces Reverse Stock Split
March 6, 2026
·
4 min read
1 of 87,378
Next
